Anti-viral compounds
Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
AbbVie Inc.
A A A A C C A A C C A C C A Y C A A A A A A A C A A A
A61K A61K A61K A61K C07D C07D A61P A61P C07D C07F A61K C07D C07D A61K Y02P C07D A61K A61K A61K A61K A61K A61K A61P C07D A61K A61K A61K
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional additional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Tammie K. Sachin V. David A. Kathy David A. Charles W. Wenke Douglas K. John T. Christopher E. Warren M. Charles A. Kevin R. Todd W. Michael D. Dachun Mark A. Lissa T. Daniel D. John K. Ryan G. Pamela L. William A. Rolf Mary E. Seble H. Allan C. Clarence J. Jean-Christophe C. Yi
Jinkerson Patel DeGoey Sarris Betebenner Hutchins Li Hutchinson Randolph Motter Kati Flentge Woller Rockway Tufano Liu Matulenko Nelson Caspi Pratt Keddy Donner Carroll Wagner Bellizzi Wagaw Krueger Maring Califano Gao